Table 1. Calculation of the standardized incidence and mortality ratios based on a cohort study on the association of hormone replacement therapy (HRT) and breast cancer (13).
a) Expected incidence in exposed study population | ||||
Age group | Number of exposed persons in each age group in the cohort (fictive) A | Breast cancer incidence in each age group per 100 000 (general German population* [19]) B- | Expected number of exposed cases of breast cancer in exposed members of each age group per year in the cohort C = A x B | Expected number of exposed cases of breast cancer in exposed members of each age group in 2.6 years in the cohort D = C x 2.6 |
50–54 | 181 736 | 221.1 | 401.8 | 1 044.7 |
55–59 | 138 119 | 286.9 | 396.3 | 1 030.4 |
60–64 | 116 311 | 299.1 | 347.9 | 904.5 |
Total | 436 166 | – | 1146.0 | 2 979.6 |
b) Expected mortality in exposed study population | ||||
Age group | Number of exposed persons in each age group in the cohort (fictive) A | Breast cancer mortality in each age group per 100 000 (general German population* [19]) B | Expected number of deaths from breast cancer in exposed members of each age group per year in the cohort C = A x B | Expected number of deaths from breast cancer in exposed members of each age group in 2.6 years in the cohort D = C x 2.6 |
50–54 | 181 736 | 39.7 | 72.1 | 187.6 |
55–59 | 138 119 | 58.3 | 80.5 | 209.4 |
60–64 | 116 311 | 75.8 | 88.2 | 229.2 |
Total | 436 166 | – | 240.8 | 626.2 |
*taken as approximation for breast cancer incidence and mortality in Great Britain